Curis (NASDAQ: CRIS) spotted trading -43.38% off 52-week high price. On the other end, the stock has been noted 235.00% away from the low price over the last 52-weeks. The stock changed 6.35% to recent value of $2.01. The stock transacted 2649273 shares during most recent day however it has an average volume of 559.6K shares. The company has 31.75M of outstanding shares and 27.15M shares were floated in the market.
Curis (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced its financial results for the fourth quarter and year ended December 31, 2018.
James Dentzer, President and Chief Executive Officer of Curis said “2018 was a pivotal year for Curis as we transitioned from a company broadly engaged in discovery research and pipeline expansion into a company singularly focused on clinical execution”. “We now have three novel programs in the clinic, all potential blockbusters and all with significant data catalysts expected in 2019.”
Dentzer continued, “With our recently announced agreement with Oberland Capital, we secured the financial flexibility needed to ensure we can continue to move forward aggressively in our clinical execution on all three programs and produce the data readouts everyone is so excited to see.
He concluded “As we move through 2019, we are focused on the development of first-in-class and best-in-class precision medicines that we hope will transform the lives of patients”.
Its earnings per share (EPS) expected to touch remained 21.40% for this year. CRIS has a gross margin of 94.70%.
According to the most recent quarter its current ratio was 2.6 that represents company’s ability to meet its current financial obligations. The price moved ahead of 59.21% from the mean of 20 days, 71.41% from mean of 50 days SMA and performed 38.28% from mean of 200 days price. Company’s performance for the week was 37.67%, 81.08% for month and YTD performance remained 191.39%.
William Wall is a self-taught investor and follows the value investing approach to picking stocks. He possesses over 10 years of investment experience, an M.B.A. from Louisiana State University, and is also certified in Risk Management Assurance. William is a Certified Internal Auditor, Data Miner, and author with a career broadly spanning over multiple business areas. He has exploited those observations and developed investment tactics within a fundamentally sound long-term investment strategy. He currently covers Earnings News category for our site.
Address: 4188 Spadafore Drive, Erie, Pennsylvania
Phone number: 814-705-9247
Email: [email protected]